1RQ

cyclopropyl[(3R)-3-({4-[6-hydroxy-2-(naphthalen-2-yl)-1H-benzimidazol-1-yl]pyrimidin-2-yl}amino)piperidin-1-yl]methanone

Created:	2013-05-09
Last modified:	2014-05-21

Find Related PDB Entry
1 entries where 1RQ is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	66
Chiral Atom Count	1
Bond Count	72
Aromatic Bond Count	27

2D diagram of 1RQ

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	cyclopropyl[(3R)-3-({4-[6-hydroxy-2-(naphthalen-2-yl)-1H-benzimidazol-1-yl]pyrimidin-2-yl}amino)piperidin-1-yl]methanone
Systematic Name (OpenEye OEToolkits)	cyclopropyl-[(3R)-3-[[4-(2-naphthalen-2-yl-6-oxidanyl-benzimidazol-1-yl)pyrimidin-2-yl]amino]piperidin-1-yl]methanone
Formula	C₃₀ H₂₈ N₆ O₂
Molecular Weight	504.582
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(N6CCCC(Nc5nc(n3c4cc(O)ccc4nc3c2cc1ccccc1cc2)ccn5)C6)C7CC7
SMILES	CACTVS	3.370	Oc1ccc2nc(n(c3ccnc(N[CH]4CCCN(C4)C(=O)C5CC5)n3)c2c1)c6ccc7ccccc7c6
SMILES	OpenEye OEToolkits	1.7.6	c1ccc2cc(ccc2c1)c3nc4ccc(cc4n3c5ccnc(n5)NC6CCCN(C6)C(=O)C7CC7)O
Canonical SMILES	CACTVS	3.370	Oc1ccc2nc(n(c3ccnc(N[C@@H]4CCCN(C4)C(=O)C5CC5)n3)c2c1)c6ccc7ccccc7c6
Canonical SMILES	OpenEye OEToolkits	1.7.6	c1ccc2cc(ccc2c1)c3nc4ccc(cc4n3c5ccnc(n5)N[C@@H]6CCCN(C6)C(=O)C7CC7)O
InChI	InChI	1.03	InChI=1S/C30H28N6O2/c37-24-11-12-25-26(17-24)36(28(33-25)22-10-7-19-4-1-2-5-21(19)16-22)27-13-14-31-30(34-27)32-23-6-3-15-35(18-23)29(38)20-8-9-20/h1-2,4-5,7,10-14,16-17,20,23,37H,3,6,8-9,15,18H2,(H,31,32,34)/t23-/m1/s1
InChIKey	InChI	1.03	GQWKCVUFYCHSLR-HSZRJFAPSA-N

Related Resource References

Resource Name	Reference
PubChem	71584212
ChEMBL	CHEMBL2334705

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.